Story perspectives
Revolutionary Breath Test for Pancreatic Cancer Trials Begin
10/31/2025
41 9
1 of 1
Story summary
- A new breath test for pancreatic cancer is trialed across 40 UK hospitals, involving about 6,000 patients.
- Imperial College London developed the test, which detects volatile organic compounds in breath to flag early cancer.
- Pancreatic Cancer UK is funding the £1.1 million study to advance early detection, addressing that 80% of cases are detected after spread.
- Diana Jupp, Chief Executive of Pancreatic Cancer UK, says the approach could save lives.
